Namida Lab is a pioneering brand with a mission to make cancer screening accessible to all through the power of tears. As a CLIA Certified High Complexity Clinical Lab and Research & Development Lab, they are committed to developing and validating tools for accurate and accessible cancer screening. Their state-of-the-art facilities and equipment support their research and development efforts, allowing them to constantly explore new methods and technologies to improve the accuracy and accessibility of screening tests.

At the heart of Namida Lab is their innovative product, Auria. It is the first at-home tear-based breast health assessment test that empowers individuals to take control of their health. This groundbreaking solution has been developed by their Chief Scientific Officer, Anna Daily, Ph.

D., who has extensive expertise in molecular biology and protein characterization. To ensure the highest level of quality and precision in their screening tests, Namida Lab has Lucas Campbell, a practicing pathologist, as their Laboratory Medical Director. With over 7 years of experience in clinical laboratory science, Kelsey Kirchner serves as the General Supervisor, overseeing all aspects of the laboratory operation.

Additionally, Prashanth Ravishankar, Ph. D., a research and development scientist, plays a crucial role in advancing technologies from the lab bench to product. Namida Lab is driven by disruptive science, innovative solutions, and proactive health.

They believe that the future of preventive care lies in empowering individual health ownership, and they are committed to developing the future of cancer screening